Skip to content

Clinical trials

Phase 3 Joint Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Joint Diseases Phase: Phase 3 Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20101
20152
20162
20172
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie6
Regeneron Pharmaceuticals2
Amgen1
Eli Lilly and Company1
Pfizer1
UCB Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Joint Diseases12
Arthritis10
Musculoskeletal Diseases9
Arthritis, Rheumatoid8
Rheumatic Diseases4
Autoimmune Diseases2
Genetic Diseases, Inborn2
Gout2
Metabolic Diseases2
Metabolism, Inborn Errors2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.